Par Technology Corp.

Par Technology Corp.

PAR

Get informed when a big investor buys or sells

+ Follow
Market Cap$636.84M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Par Technology Corp.Par Technology Corp.-8.3--9%1.30.6
$21.50

Target Price by Analysts

51.7% upsidePar Technology Target Price DetailsTarget Price
$-41.34

Current Fair Value

391.7% downside

Overvalued by 391.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$636.84 Million
Enterprise Value$1.03 Billion
Dividend Yield$- (-)
Earnings per Share$-2.09
Beta1.32
Outstanding Shares40,997,000

Return

Return on Equity-9.23%ROE
Return on Assets-5.48%
Return on Invested Capital-5.78%

Valuation & Multiples

P/E Ratio-8.3P/E Ratio
PEG24.7PEG
Price to Sales1.29Price to Sales
Price to Book Ratio0.71Price to Book Ratio
Enterprise Value to Revenue2.16
Enterprise Value to EBIT-13.9
Enterprise Value to Net Income-14
Total Debt to Enterprise0.45
Debt to Equity0.56Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 13, 2026
EPS Estimate
$0.06
Average shareholder expectation
Revenue Estimate
$116.95 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 14, 2026
EPS Estimate
$0.07
Average shareholder expectation
Revenue Estimate
$124.50 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio1.0660 57.44%
Total Calls1,963,300 92.07%
Total Puts2,092,900 316.50%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %121.31% 2.74%
Total Invested$655.19M 62.33%
Investors Holding222 3.00%

ESG Score

No data

About Par Technology Corp.

CEO: Savneet Singh

Relevant Senate Committees

Finance

This powerful committee controls taxation, trade, and entitlement spending, including Medicare pricing. As an electromedical apparatus manufacturer, Par Technology's revenue and profitability would be directly affected by tax policy, trade tariffs, and Medicare reimbursement rates for its devices.

Health, Education, Labor, and Pensions

This committee directly regulates the FDA, which is the primary regulatory body for 'Electromedical and Electrotherapeutic Apparatus Manufacturing,' giving committee members direct insight into critical approval processes and industry standards.

Veterans' Affairs

This committee directly oversees the Department of Veterans Affairs and its funding, which significantly impacts government healthcare contractors and medical device manufacturers, a category that directly includes Par Technology.